Active Shortage

CEFUROXIME FOR INJECTION, USP

STERIMAX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of CEFUROXIME FOR INJECTION, USP in Canada?

Yes. CEFUROXIME FOR INJECTION, USP 1.5G has an active shortage reported to Health Canada (last updated August 13, 2020).

When will CEFUROXIME FOR INJECTION, USP be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file6 products

Affected strength1.5G

Last updated2020-08-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

KEFUROX

PHARMACEUTICAL PARTNERS OF CANADA INC

1.5G · DIN 01927264

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

KEFUROX INJ PWS 1.5GM/ADD-VANTAGE VIAL

ELI LILLY CANADA INC

1.5G · DIN 01940252

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

ZINACEF INJECTION - PWS IV 1.5GM/VIAL

GLAXOSMITHKLINE INC

1.5G · DIN 02213540

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

ZINACEF INJ 1.5GM/VIAL

GLAXO CANADA INC

1.5G · DIN 00481890

Same strengthSame dosage formDifferent routeNo current shortage

Compare these two →

ZINACEF INJ 750MG/VIAL

GLAXO CANADA INC

750MG · DIN 00497843

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

KEFUROX INJ PWS 750MG/ADD-VANTAGE VIAL

ELI LILLY CANADA INC

750MG · DIN 01935828

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

DIN

02422301

Strength

1.5G

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

CEFUROXIME

See all CEFUROXIME products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2020-08-13

Active Shortage

Other (Please describe in comments)

Other Products from STERIMAX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAZOLAMIDE FOR INJECTION, USP

500MG · DIN 02358328

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02538431

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02456524

APRESOLINE

20MG · DIN 00723754

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02492768

AZITHROMYCIN FOR INJECTION USP

500MG · DIN 02483890